Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea
Top Cited Papers
- 5 January 2002
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 39 (2), 202-209
- https://doi.org/10.1016/s0735-1097(01)01744-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Clinical criteria and biochemical markers for the detection of systolic dysfunctionJournal of Cardiac Failure, 2000
- Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunctionAmerican Heart Journal, 1998
- Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators1Cardiovascular Research, 1997
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationThe Lancet, 1997
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Brain natriuretic peptide predicts mortality in the elderly.Heart, 1997
- Biochemistry of natriuretic peptidesJournal of Internal Medicine, 1994
- Discriminating causes of dyspnea through clinical examinationJournal of General Internal Medicine, 1993
- The diagnostic usefulness of the history of the patient with dyspneaJournal of General Internal Medicine, 1986